Infection Control

Published on 12/06/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1565 times

2 Infection Control

Note 1: This book is written to cover every item listed as testable on the Entry Level Examination (ELE), Written Registry Examination (WRE), and Clinical Simulation Examination (CSE).

The listed code for each item is taken from the National Board for Respiratory Care’s (NBRC) Summary Content Outline for CRT (Certified Respiratory Therapist) and Written RRT (Registered Respiratory Therapist) Examinations (http://evolve.elsevier.com/Sills/resptherapist/). For example, if an item is testable on both the ELE and the WRE, it will be shown simply as (Code: …). If an item is testable only on the ELE, it will be shown as (ELE code: …). If an item is testable only on the WRE, it will be shown as (WRE code: …).

Following each item’s code will be the difficulty level of the questions on that item of the ELE and WRE. (See the Introduction for a full explanation of the three question difficulty levels.) Recall (R) level questions typically expect the exam taker to recall factual information. Application (Ap) level questions are more difficult because the exam taker may have to apply factual information to a clinical situation. Analysis (An) level questions are the most challenging because the exam taker may have to use critical thinking to evaluate patient data to make a clinical decision. For example, [Difficulty: ELE is R, Ap; WRE is An].

Note 2: A review of the most recent Entry Level Examinations (ELE) has shown that an average of four questions (out of 140), or 3% of the exam, will cover infection control issues. A review of the most recent Written Registry Examinations (WRE) has shown that an average of two questions (out of 100), or 2% of the exam, will cover infection control issues. The Clinical Simulation Examination is comprehensive and may include everything that should be known or performed by an advanced level respiratory therapist.

MODULE A

1. Hand washing or cleansing

Hand washing or cleansing is probably the single most important procedure for reducing the spread of infection. Washing with plain soap and warm tap water is acceptable in most cases. Antimicrobial soap should be used if called for in the infection control protocol. In many institutions, an isopropyl alcohol and skin softener/cleansing agent is used unless the hands are obviously contaminated. When contaminated with body fluids, the hands should be washed. In any case, respiratory therapists should wash or cleanse their hands before and between each patient contact. The following times are recommended when working in a general patient care area:

The most common bacterial organisms spread by personal contact are Staphylococcus aureus, Escherichia coli, and Streptococcus species. Suspect personal contact and poor hand cleansing whenever a patient has one of these infections.

2. Standard precautions

Standard (formerly called Universal) Precautions are designed for the care of all patients, regardless of their diagnosis or presumed infection status. Barriers such as gloves and masks and other procedures are used to prevent contact with body fluids. This approach to patient care has been adopted because of the concern of health care workers and the public that the human immunodeficiency virus (HIV), hepatitis B, or other deadly pathogens may be spread unknowingly by contact. Box 2-1 includes specific standard precaution guidelines established by the Centers for Disease Control and Prevention (CDC) and the Occupational Safety and Health Administration (OSHA).

BOX 2-1 Precautions to Prevent the Spread of Infection

4. Respiratory care equipment and procedures

The following guidelines are recommended to minimize the spread of infection by equipment and procedures. Follow the manufacturer’s specific guidelines when applicable:

5. Implement transmission prevention protocols

Transmission prevention protocols are used for patients known or suspected to be infected or colonized with epidemiologically significant pathogens, which are spread through airborne or droplet transmission or by contact with dry skin or contaminated surfaces. These protocols are used in addition to Standard Precautions. The following are general guidelines and specific diseases or conditions established by the CDC for the three types of patient isolation categories. Hospitals may establish extra standards and post them at the door to the patient’s room.

a. Airborne precautions

Airborne Precautions are used in addition to Standard Precautions for patients with known or suspected illnesses transmitted by airborne droplet nuclei (these include pulmonary tuberculosis [TB], varicella [chickenpox], rubeola [measles], and avian influenza [flu]), and when severe acute respiratory syndrome (SARS) is known or strongly suspected.

6. Implement infectious disease protocols (Code: IIB4) [Difficulty: ELE: Ap; WRE: An]

MODULE B

1. Pneumovax

The Pneumovax 23 (pneumococcal vaccine polyvalent) vaccine provides protection against the 23 most prevalent or invasive types of Streptococcus pneumoniae bacteria. Patients with serious chronic illness should be immunized to prevent them from developing this very dangerous type of pneumonia. Guidelines for immunization include the following:

In any immunocompetent person 2 years of age or older who fits the following conditions:

In any immunoincompetent person 2 years of age or older who has one of the following conditions:

Revaccination is recommended in the following circumstances as long as at least 5 years have passed since the first vaccination:

A third vaccination is not recommended. In general, vaccination should be performed at least 2 weeks before certain medical procedures such as elective splenectomy or immunosuppressive therapy are started. The Pneumovax 23 intramuscular or subcutaneous injection can be given at the same time as the influenza vaccination, as long as a different arm is used for each injection.

2. Influenza

Seasonal influenza (flu) vaccination begins in September or October of each year but can be given later if necessary. Two ways to be immunized are available, and each method provides protection against three strains of flu virus. The intramuscular injection vaccine contains inactivated or killed virus and is given to healthy people and those with medical conditions. The inhaled vaccine is given only to healthy individuals between 5 and 49 years of age; pregnant women are excluded.

The flu vaccine is recommended for the following groups:

The influenza vaccination injection and Pneumovax 23 intramuscular or subcutaneous injection can be given at the same time as long as a different arm is used for each injection.

MODULE C

Decontamination is the process of disassembling, washing (to remove dried secretions or other debris), rinsing, and disinfecting or sterilizing used patient care equipment. The process results in the equipment being free of any pathogens, so that it can be used with another patient. Obviously, once disinfected, the equipment must be reassembled aseptically and stored for future use.

1. Choose the appropriate agent and method for disinfection and sterilization (ELE code: IIB1) [Difficulty: ELE: Ap, An]

a. Disinfection

Disinfection is a procedure that significantly reduces the microbial contamination of the equipment that has been processed. All disinfection processes destroy the vegetative form (the cell) of pathogenic organisms, including the vast majority of respiratory system pathogens. However, a few Bacillus-type bacteria are difficult to kill because they have a particularly tough cell wall or have spores for reproduction. Spores are analogous to seeds in that they grow into bacteria under the right conditions and are resistant to drying, heat, and many chemicals that kill the bacterial cell. Therefore a spore-forming organism may be able to reproduce itself after the cells have been killed. Obviously, disinfection can be used only on equipment that is not contaminated by spore-forming bacteria. Knowing what pathogen has infected the patient, if possible, can help the clinician determine the appropriate disinfection (or sterilization) method to be used on contaminated equipment. Some disinfecting agents kill different kinds of organisms, depending on the length of exposure time.

Another consideration in selecting the appropriate disinfection method is how the equipment will be used in patient care. Equipment or instruments that do not directly touch the patient (e.g., an electrocardiograph machine) are classified as noncritical (low risk of spreading infection) and can undergo low-level disinfection. Low-level disinfectants are agents capable of killing some vegetative bacteria, fungi, and lipophilic viruses. Equipment or instruments that touch surface mucous membranes and the skin but do not penetrate them are listed as semicritical and must undergo high-level disinfection (e.g., laryngoscope blades, a bronchoscope). Agents that kill all microorganisms except bacterial spores are classified as high-level disinfectants.

A third consideration in choosing the best disinfection method is the type of equipment that requires decontamination. Certain processes and agents can be used only on certain types of equipment. Table 2-1 lists the various ways of disinfecting reusable patient care equipment decontaminated in the hospital.

The fourth consideration to take into account is the location of the patient. The previous discussion relates to patients in the hospital or a long-term care facility. Home care patients typically will not use these methods because of the high costs. Instead, the plastics used in home care medication nebulizers, etc., usually are cleansed in the following way:

A 1.25% or higher percentage solution is classified as a low-level disinfectant and will kill most vegetative bacteria (including Pseudomonas aeruginosa) and some fungi and viruses. However, Mycobacterium tuberculosis, nonlipid viruses, and spores will not be killed.

b. Sterilization

Sterilization is a procedure that destroys all living microbial organisms and renders them unable to reproduce. All sterilization procedures destroy the vegetative forms and spores of all microscopic organisms. Examples of spore-forming bacteria include Bacillus anthracis (anthrax), Clostridium botulinum (botulism), C tetani (tetanus), and C perfringens (gas gangrene). Any equipment or instruments that penetrate body tissue (e.g., a surgical scalpel) are listed as “critical” (high risk of spreading infection) and must be sterilized before use on another patient. As was discussed previously, the method of sterilization depends on the type of equipment under consideration. Table 2-2 lists various methods of sterilization for reusable supplies and patient care equipment decontaminated in the hospital.

TABLE 2-2 Methods of Sterilization Used in the Hospital Setting for Respiratory Care–Related Equipment

Method Conditions Comments
Steam autoclave Autoclave chamber with an internal steam pressure of 15 lb per sq in, 121° C (250° F), 15 min Used with glass, cloth, bandages, unsharpened stainless steel instruments, ventilator bacteria filters.
Avoid use with many plastics used in respiratory care, rubber, dextrose solutions, sharpened stainless steel instruments, electrical devices, or machines.
Dry heat Autoclave chamber at 160° C-180” C (320° F-356°F), 2-hr use Used with glass or sharpened stainless steel instruments.
Avoid use with many plastics used in respiratory care, rubber, dextrose solutions, electric devices, or machines.
Ethylene oxide gas Specific guidelines vary depending on the manufacturer of the chamber and the supplies or equipment being sterilized. In general, a gas concentration of 800-1000 mg/L must be kept for 3-4 hr at 50%-100% relative humidity and 49° C-57° C (120° F-135” F). Great care must be taken to pre-dry all items before gassing and to properly aerate them after sterilization. Used with heat-sensitive and moisture-sensitive items, as are many plastics in respiratory care equipment.
Avoid use with supply pouches or plastic films, such as aluminum foil, nylon, thermoplastic resin (Saran), Mylar, cellophane polyamide, polyester, or other films that are not penetrated by the gas, or with PVC that has been sterilized previously by the manufacturer with gamma radiation.
GLUTARALDEHYDE SOLUTIONS
Alkaline glutaraldehyde (Cidex, Cidex 7, Sporicidin) Complete immersion. Cidex products for 10 hr; Sporicidin for 6 hr and 45 min Used with rubber and many plastics in respiratory care, especially those that are heat sensitive; care must be taken to thoroughly rinse items after they have been cleansed.
Avoid use with any item that cannot be immersed or that will absorb the solution.
Acid glutaraldehyde (Sonacide) Complete immersion for 1 hr at 60° C (140° F) Use with rubber and many plastics used in respiratory care, especially those that are heat sensitive; care must be taken to thoroughly rinse items after they have been cleansed.
Avoid use with any item that cannot be immersed or that will absorb the solution.

PVC, Polyvinyl chloride

3. Monitor the sterilization process to ensure its effectiveness (ELE code: IIB1) [Difficulty: ELE: Ap, An]

The term surveillance describes the monitoring of equipment to ensure that the disinfection or sterilization process was successful and that in-use equipment is not a source of patient contamination. Processing (chemical) indicators are used to ensure that disinfection or sterilization was done correctly. Examples include special tapes used to hold the wrapping around packages of equipment being autoclaved or placed into ethylene oxide. These tapes turn color when the autoclave has reached the proper temperature, or when the correct concentration of ethylene oxide has been reached. The color change shows the user that the package was processed correctly; therefore the package contents are probably sterile.

Another example is a biologic indicator placed into the wrapped package before sterilization. These biologic indicators are bacterial spores that are killed only if the required conditions are met. For example, the spores of Bacillus subtilis are placed onto strips of paper to be killed by ethylene oxide gas. After the equipment and spores have been sent through the sterilization process, the spores are placed into conditions favorable for growth. If no growth occurs, they are dead; therefore no other living organisms survived.

Equipment held in storage or being used in patient care also is randomly sampled for contamination. A sample is taken in three ways for culturing of possible organisms in three ways. The first involves wiping a sterile swab onto an equipment surface, and then rubbing it over a plate of growth medium or placing it into a tube of liquid broth. The second, which is used to check inside lengths of tubing, necessitates pouring a liquid broth through the tube and into a sterile container. The third involves sampling the aerosol that a nebulizer produces. A hose usually is attached to the outlet of the nebulizer. The other end of the hose is connected to a funnel, which is attached to a culture plate, where the droplets impact. In all three examples, the growth of any organism in the growth medium indicates a form of contamination. The laboratory then determines whether the organism is pathogenic. If so, measures must be taken to improve the disinfection or sterilization process.

BIBLIOGRAPHY

American Association for Respiratory Care (AARC). Guidelines for the prevention of nosocomial infections. Dallas: AARTimes, Sept. 1983.

American Respiratory Care Foundation (ARCF). Guidelines for disinfection of respiratory care equipment used in the home. Respir Care. 1988;33:801.

Carter C, Stone MK. Respiratory microbiology, infection, and infection control. In: Hess DR, MacIntyre NR, et al, editors. Respiratory care principles and practice. Philadelphia: WB Saunders, 2002.

Centers for Disease Control (CDC). Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza. http://www.cdc.gov/flu/avian/professional/infect-control.htm, May 21, 2004.

Chatburn RL, Kallstrom TJ, Bajaksouzian S. A comparison of acetic acid with a quaternary ammonium compound for disinfection of hand-held nebulizers. Respir Care. 1988;33(3):179-187.

Eubanks DH, Bone RC. Comprehensive respiratory care, ed 2. St Louis: Mosby, 1990.

Fink JB. Infection control and safety. In: Fink JB, Hunt GE, editors. Clinical practice in respiratory care. Philadelphia: Lippincott Williams & Wilkins, 1999.

Gordon SM. Principles of infection control. In Wilkins RL, Stoller JK, Kacmarek RM, editors: Egan’s fundamentals of respiratory care, ed 9, St Louis: Mosby, 2009.

Johnson & Johnson Medical: Cidexplus, 28-day solution, Arlington, TX, 1999.

Merck & Co., Inc: Pneumovax 23 (pneumococcal vaccine polyvalent), Whitehouse Station, NJ, July 2008.

OSF Saint Anthony Medical Center, Infection control precautions, Rockford, IL, 1998.

Pagana KD, Pagana TJ. Mosby’s manual of diagnostic and laboratory tests. St Louis: Mosby, 1998.

U.S. Department of Health and Human Services: Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS), version 2: Supplement I: Infection control in healthcare, home, and community settings, January 8, 2004.

U.S. Food and Drug Administration (FDA). Influenza: Vaccination still the best protection. http://www.fda.gov/fdac/features/2006/506_influenza.html, September-October 2006.

Washington JA. Infectious disease aspects of respiratory therapy. In Burton GG, Hodgkin JE, Ward JJ, editors: Respiratory care, ed 4, Philadelphia: Lippincott-Raven, 1997.

SELF-STUDY QUESTIONS FOR THE ENTRY LEVEL EXAM See page 583 for answers

SELF-STUDY QUESTIONS FOR THE WRITTEN REGISTRY EXAM See page 606 for answers